Results 191 to 200 of about 5,935,465 (357)

Severity of Illness and Mortality According to Time of Admission to Intensive Care. [PDF]

Acta Anaesthesiol Scand
Ihalainen V, Pölkki A, Bendel S, Hästbacka J, Heino S, Reinikainen M, FINNICU Research Group.   +6 more
europepmc   +1 more source

Supplementary Material for: Urinary Biomarkers of Tubular Health and Risk for Kidney Function Decline or Mortality in Diabetes

, 2023
Chen T.K., Coca S.G., Thiessen-Philbrook H.R., Heerspink H.J.L., Wassim Obeid, Ix J., Linda F. Fried, Bonventre J.V., El-Khoury J.M., Shlipak M.G., Parikh C.R.   +10 more
openalex   +1 more source

CAR T‐Cell Therapy in Neurology: A Scoping Review of Neuro‐Oncology, Autoimmune Diseases & Neurotoxicity

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Chimeric antigen receptor (CAR) T‐cell therapy has been investigated in neurological diseases, encompassing both central nervous system malignancies and autoimmune disorders, thereby extending its application beyond hematological cancers.
Omar Alqaisi, Mohammed Dibas, Patricia Tai, Ala Dibas, Osama Souied, Suhair Al‐Ghabeesh   +5 more
wiley   +1 more source

Examining Survival of People Diagnosed With HIV in Florida Between 2015 and 2021 After a Late, Delayed, or Timely Diagnosis. [PDF]

J Acquir Immune Defic Syndr
Parisi CE, Parisi CE, Chichetto N, Li Z, Kwara A, Canidate SS, Cohen C, Cook RL.   +7 more
europepmc   +1 more source

Higher tree diversity is linked to higher mortality

, 2022
Eric B. Searle
openalex   +1 more source

The Renal Activity Index for Lupus Identifies Active Renal Disease and Treatment Response in Adult Patients With Systemic Lupus Erythematosus and Lupus Nephritis

Arthritis Care &Research, EarlyView.
Objective We evaluated the ability of the Renal Activity Index for Lupus (RAIL) to discriminate active lupus nephritis (LN) in adult patients with active systemic lupus erythematosus (SLE) and differentiate LN treatment response. Methods Urine samples from adults with biopsy‐proven active class III and IV LN from TULIP‐LN (active LN group ...
Hermine I. Brunner, Ellen M. Cody, Prasad Devarajan, Bin Huang, Chen Chen, Dominic Sinibaldi, Madhu Ramaswamy, Jacob Knagenhjelm, Frederick Jones, Philip Z. Brohawn, Raj Tummala, Catharina Lindholm, Wendy I. White   +12 more
wiley   +1 more source

Validation of a Genetic Risk Score Combined With Clinical Variables for Predicting Pulmonary Fibrosis in Early Rheumatoid Arthritis

Arthritis Care &Research, EarlyView.
Objective Pulmonary fibrosis (PF) is a severe extra‐articular manifestation of rheumatoid arthritis (RA). This study aimed to externally validate a genetic risk score (GRS) and a combined risk score (CRS) for predicting the risk of RA‐associated PF in an independent cohort of patients with early RA.
Mikael Brink, Austin Wheeler, Bryant R. England, Solbritt Rantapää‐Dahlqvist   +3 more
wiley   +1 more source

Research Topics and Trends in MIMIC-IV: A Large ICU Database Relevant for Critical Care Nursing. [PDF]

Nurs Crit Care
Ho YS, Ben Salem A, Kchaou M, Dere A, Mzid Y, Turki H.   +5 more
europepmc   +1 more source

Supplementary Material for: Association of intradialytic hypertension with future cardiovascular events and mortality in hemodialysis patients: effects of ambulatory blood pressure

, 2023
Ikechukwu Achilonu, Xusheng Bai, Aiqiang Xu, Li-Yu Lin, Heinrich C. Hoppe, Heini W. Dirr, Ms.Babita Jharia, Milind A. Phadnis, Christin Bauer   +8 more
openalex   +1 more source

Pharmacokinetics, Pharmacodynamics, and Safety of Subcutaneous Belimumab in Pediatric Patients With Systemic Lupus Erythematosus: A Multicenter, Open‐Label Trial

Arthritis Care &Research, EarlyView.
Objective This study aimed to characterize the pharmacokinetics, pharmacodynamics, safety, and exploratory efficacy of subcutaneous belimumab in pediatric patients with active systemic lupus erythematosus (SLE) receiving standard therapy. Methods This single‐arm, multicenter, open‐label trial (GSK study 200908; ClinicalTrials.gov identifier ...
Hermine I. Brunner, Jordi Antón, Inmaculada Calvo‐Penadés, Richard Dimelow, Gerd Horneff, Sylvia Kamphuis, Rebecca Marino, Andre van Maurik, Kirsten Minden, Masaaki Mori, Josephine Ocran‐Appiah, Christel Wilkinson, Yuichi Yamasaki, Deepak Assudani, for the Pediatric Rheumatology Collaborative Study Group (PRCSG) and Paediatric Rheumatology International Trials Organisation (PRINTO) Network investigators   +14 more
wiley   +1 more source